Healthcare
Healthcare AI spending reaches $3.7 billion as investment shifts to care and drug discovery
Menlo Ventures said healthcare AI spending reached $3.7 billion in 2026 and is moving beyond paperwork into drug discovery and patient care.
Menlo Ventures reported that healthcare AI spending reached $3.7 billion in 2026, representing a 2.5-fold increase over the prior year. The firm said spending is shifting from administrative paperwork toward drug discovery and patient care.
The report describes a change in the composition of healthcare-AI investment. Administrative automation remains relevant, but organizations are increasingly directing resources toward applications closer to clinical development and delivery.
Drug discovery can use AI to prioritize candidates and analyze biological data, while patient-care applications may support clinical workflows and decision-making. The reported spending figure signals broader commercialization across the healthcare ecosystem.
The source is a venture-capital firm’s industry report, so its figures reflect the methodology and market coverage used by Menlo Ventures. The report does not establish that every investment produced clinical benefits, but it identifies a significant trend in healthcare technology spending.
Original source: Fidelity News